Polyoxidonium® (INN: Azoximer bromide) is an original Russian medication, which has been widely used in Russian clinical practice and exported to foreign countries for over 20 years.
To date, Sputnik V has been registered in 68 countries with a total population of over 3.7 billion people, which is nearly half of the global population.
Russia actively fosters localization of its vaccine production abroad, which is based on technology transfer, while agreements were inked with several foreign companies.